125 related articles for article (PubMed ID: 38578829)
1. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2024 Apr; 43(4):113063. PubMed ID: 38578829
[No Abstract] [Full Text] [Related]
2. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Lui W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2018 Jun; 23(12):3698. PubMed ID: 29925010
[No Abstract] [Full Text] [Related]
3. Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45.
Lee BH
Urol Oncol; 2017 Sep; 35(9):578-579. PubMed ID: 28780132
[TBL] [Abstract][Full Text] [Related]
4. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2018 Apr; 23(1):313-326.e5. PubMed ID: 29617669
[TBL] [Abstract][Full Text] [Related]
5. Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.
Modi PK; Singer EA
Ann Transl Med; 2016 Apr; 4(7):143. PubMed ID: 27162793
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.
Haake SM; Weyandt JD; Rathmell WK
Mol Cancer Res; 2016 Jul; 14(7):589-98. PubMed ID: 27330105
[TBL] [Abstract][Full Text] [Related]
7. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
[TBL] [Abstract][Full Text] [Related]
8. Survival prediction of kidney renal papillary cell carcinoma by comprehensive LncRNA characterization.
Lan H; Zeng J; Chen G; Huang H
Oncotarget; 2017 Dec; 8(67):110811-110829. PubMed ID: 29340018
[TBL] [Abstract][Full Text] [Related]
9. A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma.
Fahey CC; Rathmell WK
Mol Cell Oncol; 2015; 2(2):e979686. PubMed ID: 27308442
[TBL] [Abstract][Full Text] [Related]
10. Quantification of eosinophilic area and its potential molecular feature in clear cell renal cell carcinoma.
Wen N; Li X; Lu J; Pan L; Yang P; Zhang Y; Chen K; Cao Y
Jpn J Clin Oncol; 2024 Jun; 54(6):689-698. PubMed ID: 38366664
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Li J; Guo L; Chai L; Ai Z
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830966. PubMed ID: 30852945
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of the ATP-binding Cassette Subfamily B Across Renal Cancers Identifies ABCB8 Overexpression in Phenotypically Aggressive Clear Cell Renal Cell Carcinoma.
Blajan I; Miersch H; Schmidt D; Kristiansen G; Perner S; Ritter M; Ellinger J; Klümper N
Eur Urol Focus; 2021 Sep; 7(5):1121-1129. PubMed ID: 33011150
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma: molecular characterization and evolving treatment paradigms.
Ball MW; Singer EA; Srinivasan R
Curr Opin Oncol; 2017 May; 29(3):201-209. PubMed ID: 28252459
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the miRNA biogenesis components DICER1, DROSHA, DGCR8 and AGO2 in clear cell renal cell carcinoma in both a Korean cohort and the cancer genome atlas kidney clear cell carcinoma cohort.
Lee SS; Min H; Ha JY; Kim BH; Choi MS; Kim S
Oncol Lett; 2019 Oct; 18(4):4337-4345. PubMed ID: 31516620
[TBL] [Abstract][Full Text] [Related]
16. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW
Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202
[TBL] [Abstract][Full Text] [Related]
17. The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
Wang J; Chen M; Dang C; Zhang H; Wang X; Yin J; Jia R; Zhang Y
Urol Int; 2022; 106(4):344-351. PubMed ID: 34265766
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
Xu W; Jiang X; Guan C; Gu M
Medicine (Baltimore); 2020 Nov; 99(46):e23181. PubMed ID: 33181696
[TBL] [Abstract][Full Text] [Related]
19. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values.
Li X; Li H; Yang C; Liu L; Deng S; Li M
Front Oncol; 2020; 10():567970. PubMed ID: 33194650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
